Comparison of Intrathecal Concentrations of Acyclovir following Epidural and Intravenous Administration in Rats.

BACKGROUND Herpes zoster is a disease caused by reactivation of varicella-zoster virus in sensory cranial nerves and dorsal root ganglion. Our presumption was that epidural administration of acyclovir near the viral burden could be more advantageous than intravenous (IV) administration. The cerebrospinal fluid concentration of acyclovir after epidural administration was determined to be higher than that after IV administration in rats. OBJECTIVE In this study, we tested the hypothesis that the concentration of acyclovir in CSF after epidural administration is higher than that achieved after IV administration in rats. STUDY DESIGN A randomized controlled animal trial. METHODS A total of 30 adult male Sprague-Dawley rats were used. The rats were randomly divided into 2 equal groups, epidural (Group Epi) and IV (Group IV) administration groups (n = 15). Group Epi was further subdivided into 3 groups according to acyclovir dosage; each group comprised 5 animals receiving injections at dosages of 0.3 mg, 0.6 mg, and 0.9 mg. Group IV was also subdivided into 3 groups receiving dosages of 3 mg, 6 mg, and 9 mg. We measured CSF and plasma acyclovir concentrations one hour after administration. RESULTS In Group Epi, the median plasma concentrations of acyclovir were lower than that in CSF (P < 0.05). In Group IV, the median plasma concentrations of acyclovir were significantly higher than that in CSF (P < 0.05). The CSF concentrations of acyclovir in Group Epi were significantly higher than that in Group IV (P < 0.05). The plasma concentrations of acyclovir in Group Epi were significantly lower than that in Group IV (P < 0.05). LIMITATIONS There were no references of equivalent dosages of acyclovir between IV and epidural administration. However, it is obvious in this study that epidural administration of a low dose of acyclovir can more effectively increase its concentration in the intrathecal space than IV administration. CONCLUSIONS Epidural administration of acyclovir provides superior drug concentrations in the intrathecal space compared to IV administration. KEY WORDS Acyclovir, epidural injection, herpes zoster, varicella zoster virus.

[1]  Jae Hun Kim.  Risk Factor and Prevention of Postherpetic Neuralgia , 2015, The Korean journal of pain.

[2]  E. Garbe,et al.  Incidence of herpes zoster and its complications in Germany, 2005-2009. , 2015, The Journal of infection.

[3]  S. Tyring,et al.  Varicella zoster: an update on current treatment options and future perspectives , 2014, Expert opinion on pharmacotherapy.

[4]  M. Rowbotham,et al.  Natural history of herpes zoster: Late follow-up of 3.9 years (n=43) and 7.7 years (n=10) , 2013, PAIN®.

[5]  Kyung-Hoon Kim.  Herpes Zoster Vaccination , 2013, The Korean journal of pain.

[6]  J. Cohen.  Clinical practice: Herpes zoster. , 2013, The New England journal of medicine.

[7]  Dong Kyu Lee,et al.  The neurological safety of intrathecal acyclovir in rats. , 2012, Pain physician.

[8]  W. Goins,et al.  Varicella zoster virus-induced pain and post-herpetic neuralgia in the human host and in rodent animal models , 2011, Journal of NeuroVirology.

[9]  R. Cohrs,et al.  Review: The neurobiology of varicella zoster virus infection , 2011, Neuropathology and applied neurobiology.

[10]  A. Oaklander,et al.  Management of herpes zoster and post-herpetic neuralgia now and in the future. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[11]  C. Ecoffey,et al.  Epidural, intrathecal and plasma pharmacokinetic study of epidural ropivacaine in PLGA-microspheres in sheep model. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[12]  Ning Chen,et al.  Antiviral treatment for preventing postherpetic neuralgia. , 2009, The Cochrane database of systematic reviews.

[13]  H. Benzon,et al.  Evidence-Based Case Report: The Prevention and Management of Postherpetic Neuralgia With Emphasis on Interventional Procedures , 2008, Regional Anesthesia & Pain Medicine.

[14]  K. Schmader,et al.  Natural history and treatment of herpes zoster. , 2008, The journal of pain : official journal of the American Pain Society.

[15]  A. Oaklander.  Mechanisms of pain and itch caused by herpes zoster (shingles). , 2008, The journal of pain : official journal of the American Pain Society.

[16]  M. Rowbotham,et al.  Natural history of pain following herpes zoster , 2007, Pain.

[17]  L. Ståhle,et al.  The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment. , 2006, The Journal of antimicrobial chemotherapy.

[18]  C. Bernards.  Sophistry in Medicine: Lessons From the Epidural Space , 2004, Regional Anesthesia & Pain Medicine.

[19]  S. Strumia,et al.  Neurotoxicity of acyclovir and valacyclovir in a hemodialyzed patient , 2004, European journal of neurology.

[20]  M. Almond.  Aciclovir and valaciclovir neurotoxicity in patients with renal failure. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  Brian R. Phillips,et al.  Epidural, Cerebrospinal Fluid, and Plasma Pharmacokinetics of Epidural Opioids (Part 1): Differences among Opioids , 2003, Anesthesiology.

[22]  D. Gilden,et al.  Varicella-Zoster virus infections of the nervous system: clinical and pathologic correlates. , 2001, Archives of pathology & laboratory medicine.

[23]  C. Bernards,et al.  Comparative Spinal Distribution and Clearance Kinetics of Intrathecally Administered Morphine, Fentanyl, Alfentanil, and Sufentanil , 2000, Anesthesiology.

[24]  Robert W. Johnson.  Herpes Zoster and Postherpetic Neuralgia , 1997, Drugs & aging.

[25]  D. Shen,et al.  A pharmacokinetic approach to resolving spinal and systemic contributions to epidural alfentanil analgesia and side-effects , 1995, Pain.

[26]  L. Davis,et al.  The vasculopathy of varicella‐zoster virus encephalitis , 1995, Annals of neurology.

[27]  J. S. Goldberg,et al.  Use of patient-controlled analgesia to compare the efficacy of epidural to intravenous fentanyl administration. , 1992, Anesthesia and analgesia.

[28]  D. Kooy,et al.  Post-herpetic neuralgia: Further post-mortem studies of cases with and without pain , 1991, Pain.

[29]  A. Dickenson,et al.  Intrathecal opioids, potency and lipophilicity , 1989, Pain.

[30]  P. Hartvig,et al.  Pharmacokinetics of Epidural Morphine and Meperidine in Humans , 1987, Anesthesiology.

[31]  B. Bean,et al.  Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster. , 1985, The Journal of infectious diseases.

[32]  T. Hedner,et al.  Pharmacokinetic Aspects of Epidural Morphine Analgesia , 1983, Anesthesiology.